×
About 23,826 results

ALLMedicine™ Neuroblastoma Center

Research & Reviews  11,631 results

Apelin-13 protects human neuroblastoma SH-SY5Y cells against amyloid-beta induced neuro...
https://doi.org/10.1515/jbcpp-2020-0294
Journal of Basic and Clinical Physiology and Pharmacology; Samandari-Bahraseman MR, Elyasi L

May 12th, 2021 - We investigated the effect of apelin-13 on the cellular model of AD, amyloid-β (Aβ) treated SH-SY5Y cells in rats. The SH-SY5Y cells were pretreated with different doses of apelin-13 (1, 2.5, 5, and 10 μg/mL), half an hour before adding 50% Aβ tre...

Muscle mass change during chemotherapy in children with high-risk neuroblastoma: a retr...
https://doi.org/10.1007/s00431-021-04106-y
European Journal of Pediatrics; Nakamura N, Kishimoto K et. al.

May 10th, 2021 - The clinical characteristics, cause, and risk factors of sarcopenia are unclear in children. The aim of this study was to describe the course of and identify the factors related to muscle mass change during chemotherapy in children with neuroblast...

Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy.
https://doi.org/10.1080/01677063.2021.1892095
Journal of Neurogenetics; Burke EA, Sturgeon M et. al.

May 10th, 2021 - KCTD7 is a member of the potassium channel tetramerization domain-containing protein family and has been associated with progressive myoclonic epilepsy (PME), characterized by myoclonus, epilepsy, and neurological deterioration. Here we report fou...

Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a si...
https://doi.org/10.1080/08880018.2021.1922557
Pediatric Hematology and Oncology; Tarnasky AM, Achey MA et. al.

May 10th, 2021 - Pediatric neuroblastoma (NB) patients receive multi-modal therapy and may experience care fragmented among multiple institutions with a significant travel burden, which has been associated with poor outcomes for some adult cancers. We hypothesized...

Virgin Coconut Oil-Induced Neuroprotection in Lipopolysaccharide-Challenged Rats is Med...
https://doi.org/10.1080/19390211.2020.1830223
Journal of Dietary Supplements; Rahim NS, Lim SM et. al.

May 8th, 2021 - Neuroinflammation is associated with neuronal cell death and could lead to chronic neurodegeneration. This study investigated the neuroprotective potential of virgin coconut oil (VCO) against lipopolysaccharide (LPS)-induced cytotoxicity of neurob...

see more →

Guidelines  7 results

Dr. Alice Yu, Pioneer in Immunotherapy for Neuroblastoma, to Receive Pediatric Oncology Award
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200152/full/

May 19th, 2020 - Alice Yu, MD, PhD, of the University of California San Diego School of Medicine, will receive the 2020 Pediatric Oncology Award. The award, first presented in 2002, recognizes a pediatric oncologist who has demonstrated outstanding leadership or a...

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132052
Pediatric Blood & Cancer; Parikh NS, Howard SC et. al.

Mar 26th, 2015 - Neuroblastoma is the most common extracranial solid tumor in childhood in high-income countries (HIC), where consistent treatment approaches based on clinical and tumor biological risk stratification have steadily improved outcomes. However, in lo...

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the In...
https://doi.org/10.1148/radiol.11101352
Radiology Brisse HJ, McCarville MB et. al.

May 18th, 2011 - Neuroblastoma is an enigmatic disease entity; some tumors disappear spontaneously without any therapy, while others progress with a fatal outcome despite the implementation of maximal modern therapy. However, strong prognostic factors can accurate...

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696761
British Journal of Cancer; Beiske K, Burchill SA et. al.

Apr 29th, 2009 - Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neuroblastoma. Its accurate and sensitive assessment can facilitate optimal treatment decisions. The International Neuroblastoma Risk Group (INRG) Task...

Neuroblastoma Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq?cid=eb_govdel

Neuroblastoma is the most common extracranial solid tumor in childhood. More than 650 cases are diagnosed each year in the United States.[4,5] The prevalence is about 1 case per 7,000 live births; the incidence is about 10.54 cases per 1 million p...

see more →

Drugs  85 results see all →

Clinicaltrials.gov  11,953 results

Apelin-13 protects human neuroblastoma SH-SY5Y cells against amyloid-beta induced neuro...
https://doi.org/10.1515/jbcpp-2020-0294
Journal of Basic and Clinical Physiology and Pharmacology; Samandari-Bahraseman MR, Elyasi L

May 12th, 2021 - We investigated the effect of apelin-13 on the cellular model of AD, amyloid-β (Aβ) treated SH-SY5Y cells in rats. The SH-SY5Y cells were pretreated with different doses of apelin-13 (1, 2.5, 5, and 10 μg/mL), half an hour before adding 50% Aβ tre...

Muscle mass change during chemotherapy in children with high-risk neuroblastoma: a retr...
https://doi.org/10.1007/s00431-021-04106-y
European Journal of Pediatrics; Nakamura N, Kishimoto K et. al.

May 10th, 2021 - The clinical characteristics, cause, and risk factors of sarcopenia are unclear in children. The aim of this study was to describe the course of and identify the factors related to muscle mass change during chemotherapy in children with neuroblast...

Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy.
https://doi.org/10.1080/01677063.2021.1892095
Journal of Neurogenetics; Burke EA, Sturgeon M et. al.

May 10th, 2021 - KCTD7 is a member of the potassium channel tetramerization domain-containing protein family and has been associated with progressive myoclonic epilepsy (PME), characterized by myoclonus, epilepsy, and neurological deterioration. Here we report fou...

Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a si...
https://doi.org/10.1080/08880018.2021.1922557
Pediatric Hematology and Oncology; Tarnasky AM, Achey MA et. al.

May 10th, 2021 - Pediatric neuroblastoma (NB) patients receive multi-modal therapy and may experience care fragmented among multiple institutions with a significant travel burden, which has been associated with poor outcomes for some adult cancers. We hypothesized...

Heritability Genes Identified in Childhood Neuroblastoma
https://ascopost.com/issues/may-10-2021/heritability-genes-identified-in-childhood-neuroblastoma/

May 9th, 2021 - Researchers have made progress in unravelling the genetic underpinnings of pediatric neuroblastoma. Two main inherited pathogenic genetic variants have been identified and appear to be associated with worse outcomes: the ALK gene and loss of funct...

see more →

News  133 results

Novel UK Developed Immunotherapy Shows Promise Against Neuroblastoma
https://www.medscape.com/viewarticle/941775

Nov 30th, 2020 - A novel chimeric antigen receptor (CAR) T-cell therapy developed by researchers at University College London (UCL) to target cancerous tumours has shown promising early results in children with neuroblastoma. In the UCL study, paediatric patients’...

New Drug Approved for Neuroblastoma Based on MSKCC Research
https://www.medscape.com/viewarticle/941675

Nov 25th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval for a new drug for certain patients with neuroblastoma based on response rate results in small open-label trials. The drug is naxitamab (Danyelza, Y-mAbs Therapeutics), a h...

Dr. Alice Yu, Pioneer in Immunotherapy for Neuroblastoma, to Receive Pediatric Oncology Award
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200152/full/

May 19th, 2020 - Alice Yu, MD, PhD, of the University of California San Diego School of Medicine, will receive the 2020 Pediatric Oncology Award. The award, first presented in 2002, recognizes a pediatric oncologist who has demonstrated outstanding leadership or a...

Neuroblastoma: Osmosis Study Video
https://www.medscape.com/viewarticle/926532

Mar 26th, 2020 - Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy. It is a neuroendocrine tumor, arising from any neural crest element of the sympathetic nervous system. It most frequently originates in ...

IVF With Frozen Embryos Linked With Higher Risk for Blastoma, Leukemia
https://www.staging.medscape.com/viewarticle/922436

Dec 11th, 2019 - (Reuters Health) - When frozen embryos are used during in vitro fertilization (IVF), the resulting children have a slightly higher risk for certain types of cancer, evidence from Denmark suggests. Analyzing health records of more than a million Da...

see more →

Patient Education  17 results see all →